MDMA (ecstasy) Use is Associated with Reduced BOLD Signal Change During Semantic Recognition in Abstinent Human Polydrug Users: a Preliminary FMRI Study

Overview

Journal J Psychopharmacol

Publisher Sage Publications

Specialty Pharmacology

Date 2009 Mar 24

PMID 19304866

Citations 8

Authors

V Raj

H C Liang

N D Woodward

A L Bauernfeind

J Lee

M S Dietrich

S Park

R L Cowan

Affiliations

Soon will be listed here.

Abstract

3,4-methylenedioxymethamphetamine (MDMA) users have impaired verbal memory, and voxel-based morphometry has shown decreased grey matter in Brodmann area (BA) 18, 21 and 45. Because these regions play a role in verbal memory, we hypothesized that MDMA users would show altered brain activation in these areas during performance of a functional magnetic resonance imaging (fMRI) task that probed semantic verbal memory. Polysubstance users enriched for MDMA exposure participated in a semantic memory encoding and recognition fMRI task that activated left BA 9, 18, 21/22 and 45. Primary outcomes were percent blood oxygen level-dependent signal change in left BA 9, 18, 21/22 and 45, accuracy and response time. During semantic recognition, lifetime MDMA use was associated with decreased activation in left BA 9, 18 and 21/22 but not 45. This was partly influenced by contributions from cannabis and cocaine use. MDMA exposure was not associated with accuracy or response time during the semantic recognition task. During semantic recognition, MDMA exposure was associated with reduced regional brain activation in regions mediating verbal memory. These findings partially overlap with previous structural evidence for reduced grey matter in MDMA users and may, in part, explain the consistent verbal memory impairments observed in other studies of MDMA users.

Citing Articles

The functional connectome of 3,4-methyldioxymethamphetamine-related declarative memory impairments.

Coray R, Zimmermann J, Haugg A, Baumgartner M, Steuer A, Seifritz E Hum Brain Mapp. 2023; 44(15):5079-5094.

PMID: 37530403 PMC: 10502674. DOI: 10.1002/hbm.26438.

Resting state functional connectivity in alcohol users and co-users of other substances.

Morris V, Syan S, MacKillop J, Amlung M Psychiatry Res Neuroimaging. 2022; 321:111461.

PMID: 35217411 PMC: 9040506. DOI: 10.1016/j.pscychresns.2022.111461.

fNIRS suggests increased effort during executive access in ecstasy polydrug users.

Roberts C, Montgomery C Psychopharmacology (Berl). 2014; 232(9):1571-82.

PMID: 25391436 DOI: 10.1007/s00213-014-3795-8.

Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Watkins T, Raj V, Lee J, Dietrich M, Cao A, Blackford J Psychopharmacology (Berl). 2012; 227(1):41-54.

PMID: 23241648 PMC: 3615064. DOI: 10.1007/s00213-012-2936-1.

MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Anneken J, Cunningham J, Collins S, Yamamoto B, Gudelsky G J Neuroimmune Pharmacol. 2012; 8(1):58-65.

PMID: 23179355 PMC: 3587367. DOI: 10.1007/s11481-012-9420-x.

References

Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J . Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug Alcohol Depend. 2005; 78(3):317-23. DOI: 10.1016/j.drugalcdep.2004.12.002. View

Reneman L, Majoie C, Habraken J, den Heeten G . Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology. 2001; 220(3):611-7. DOI: 10.1148/radiol.2202001602. View

Sneider J, Pope Jr H, Silveri M, Simpson N, Gruber S, Yurgelun-Todd D . Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. Eur Neuropsychopharmacol. 2008; 18(8):612-9. PMC: 2518664. DOI: 10.1016/j.euroneuro.2008.04.016. View

Lee A, Robbins T, Graham K, Owen A . "Pray or Prey?" dissociation of semantic memory retrieval from episodic memory processes using positron emission tomography and a novel homophone task. Neuroimage. 2002; 16(3 Pt 1):724-35. DOI: 10.1006/nimg.2002.1101. View

Semple D, Ebmeier K, Glabus M, OCarroll R, Johnstone E . Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry. 2000; 175:63-9. DOI: 10.1192/bjp.175.1.63. View

Wish E, Fitzelle D, OGrady K, Hsu M, Arria A . Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health. 2006; 55(2):99-104. PMC: 3005618. DOI: 10.3200/JACH.55.2.99-104. View

Robbins T . Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol. 2005; 493(1):140-6. DOI: 10.1002/cne.20717. View

Logothetis N, Pfeuffer J . On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging. 2005; 22(10):1517-31. DOI: 10.1016/j.mri.2004.10.018. View

Friedman L, Kenny J, Wise A, Wu D, Stuve T, Miller D . Brain activation during silent word generation evaluated with functional MRI. Brain Lang. 1998; 64(2):231-56. DOI: 10.1006/brln.1998.1953. View

10.

Fitzgerald P, Oxley T, Laird A, Kulkarni J, Egan G, Daskalakis Z . An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res. 2006; 148(1):33-45. DOI: 10.1016/j.pscychresns.2006.04.006. View

11.

Chang L, Yakupov R, Cloak C, Ernst T . Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain. 2006; 129(Pt 5):1096-112. DOI: 10.1093/brain/awl064. View

12.

Daumann Jr J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E . Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry. 2004; 56(5):349-55. DOI: 10.1016/j.biopsych.2004.06.011. View

13.

Morgan M . Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl). 2000; 152(3):230-48. DOI: 10.1007/s002130000545. View

14.

de Win M, Reneman L, Reitsma J, den Heeten G, Booij J, van den Brink W . Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl). 2004; 173(3-4):376-82. DOI: 10.1007/s00213-003-1723-4. View

15.

Baxter M, Gaffan D, Kyriazis D, Mitchell A . Dorsolateral prefrontal lesions do not impair tests of scene learning and decision-making that require frontal-temporal interaction. Eur J Neurosci. 2008; 28(3):491-9. PMC: 2522287. DOI: 10.1111/j.1460-9568.2008.06353.x. View

16.

Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E . Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Brain Res Cogn Brain Res. 2003; 16(3):479-87. DOI: 10.1016/s0926-6410(03)00075-2. View

17.

Jacobsen L, Mencl W, Pugh K, Skudlarski P, Krystal J . Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects. Psychopharmacology (Berl). 2003; 173(3-4):383-90. DOI: 10.1007/s00213-003-1679-4. View

18.

Kalechstein A, De La Garza 2nd R, Mahoney 3rd J, Fantegrossi W, Newton T . MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl). 2006; 189(4):531-7. DOI: 10.1007/s00213-006-0601-2. View

19.

Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E . Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl). 2004; 180(4):607-11. DOI: 10.1007/s00213-004-2002-8. View

20.

Fantegrossi W, Woolverton W, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G . Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology. 2004; 29(7):1270-81. DOI: 10.1038/sj.npp.1300442. View